Most brands begin with clarity—born from a specific insight, serving a defined need at a particular moment in the market. Over time, however, a brand’s trajectory is shaped not only by external forces like category growth and innovation, but by internal ones as well: how leadership evolves, how the founder’s intent is translated at scale, how stakeholder relationships mature, and how internal culture responds to pressure.
Almost 25 years after its founding, BioPure USA was facing existential questions—about its role, relevance, and long-term direction.
By mid-2024, BioPure USA recognized that these forces were no longer incremental challenges. They were signals that the brand had reached a decisive inflection point. What the company faced were not tactical issues, but existential questions—about its role, relevance, and long-term direction.
The BioPure USA Challenges
Founded in 2001 by Johanna Dean, BioPure USA was built around providing pure, high-quality botanical supplements, sustainably sourced and designed to support complex health challenges. Its chosen channel was the healthcare professional market and its growth was closely tied to its long-standing product endorsement with Dr. Dietrich Klinghardt. Through his academy, his teachings in Autonomic Response Testing, and his proprietary formulations and endorsements of several targeted BioPure supplements, Klinghardt had played a formative role in shaping many of Biopure’s formulations and protocols.
Over time, that dynamic became increasingly complex. Dr. Klinghardt had helped initiate the creation of additional supplement companies in the UK and mainland Europe—offering many of the same botanical formulas produced by Biopure USA. In a global, digital marketplace where geographic boundaries are porous, this created confusion. Customers in the U.S. could easily access multiple versions of identical products, and informal promotion of different brands made purchasing behavior unpredictable.
Internally, BioPure was also working to organize itself for sustainable, long-term growth—while remaining true to its values and integrity.
“When Johanna reached out to Pure Branding, she recognized that Biopure’s overreliance on a single influential clinical voice was not sustainable,” said Yadim Medore, Founder and CEO of Pure Branding. “She also realized that Biopure’s brand equity was eroding among the long-standing practitioners and patients who had built the business, while at the same time, the brand was becoming less visible to newer audiences seeking solutions for complex health challenges.And, when customers can freely substitute one identical product for another, brand equity begins to erode—especially when that substitution is driven by your strongest advocate.”
The Biopure Diagnosis
The first phase of Pure Branding’s legacy rebrand process is an immersive, rigorous exploration of the organization—its history, beliefs, culture, and future aspirations. For BioPure, this culminated in a three-day, in-person workshop with the leadership team in November 2024.
“As is often the case in this phase, we spent significant time exploring the culture of the organization,” said Peter Littell, Director of Strategy & Research at Pure Branding. “Leadership was candid about where the brand had struggled, where it had succeeded, and the desire for a deeper, more meaningful transformation. The work centered on uncovering an authentic belief system that could re-energize the brand from within.”
That belief system emerged as Salutogenesis—a health philosophy known in Europe and long held by Dean herself. Unlike traditional disease-focused models, salutogenesis emphasizes the factors that support health, resilience, and well-being.
Through the workshop, Dean and her team saw how this philosophy could become the foundation of BioPure’s identity—allowing the brand to differentiate itself meaningfully, while still honoring and complementing its historical association with Dr. Klinghardt.
“Having permission and encouragement to fully integrate my belief in salutogenesis into BioPure was revelatory,” said Dean. “It showed us how we could better control our destiny as a brand, remain an authentic ally to chronic care communities, and honor bio-individuality—while also providing more accessible education and guidance. We finally had a coherent way to meet crisis with clarity.”
“After the workshop, I felt hopeful and reinvigorated,” added Michele Milligan, Biopure Health’s Clinical Educator & Product Manager. “I could clearly see how we could collaborate more fully and work toward something larger than ourselves.”
Validating the Opportunity
Because BioPure’s future growth depended heavily on its relationship with healthcare practitioners, the next step was to validate whether a salutogenic positioning would resonate beyond the leadership team.
“We conducted quantitative research with both HCP customers and non-customers,” said Littell. “We assessed how BioPure was perceived across the attributes most important to its target practitioners, explored opportunities for differentiation—particularly around environmental health—and confirmed something critical: the integrative practitioner community would strongly support a brand rooted in a salutogenic approach.”
“From a customer-journey perspective, we also needed to understand how much the brand should remain anchored to Dr. Klinghardt,” said Samantha Brewster, VP of Client Strategy & Activation at Pure Branding. “We examined potential new allies, the types of protocols practitioners were seeking, and how much education they wanted directly from BioPure. This work helped us define the target HCP more clearly—what they believe, how they make decisions, and what would encourage deeper engagement with the brand.”
Prescription for Growth
With confidence that salutogenesis could serve as a powerful foundation, the next phase focused on defining a clear and compelling brand and growth strategy.
“For the first time in the brand’s history, it had to invest beyond the influence of Dr. Klinghardt,” said Brewster. “Establishing the brand elements like the center and pillars directed us toward owning a niche in the integrative HCP channel. Our growth strategy provided the path forward for intentional investment in content and education that customers were craving from the brand.”
“This was the moment where the ideas of health creation and resilience truly came into focus,” said Dean. “For the first time, we could clearly see how BioPure could exist within the broader integrative landscape. The strategy revealed a path toward more meaningful relationships with our customers—shifting from transactional interactions to deeper engagement.”
